Evidence map›Paper›PMID 21503765›Full record

ReviewVirchows Archiv : an international journal of pathology2011

Classifications of lymphoma; reflections of time and technology.

Clive R Taylor, Robert J Hartsock

Abstract readHistorical ArticleReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Inflammatory Cells in Diffuse Large B Cell Lymphoma.Journal of clinical medicine · 2020
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Clive R TaylorDepartment of Pathology, Keck School of Medicine, Los Angeles, CA, USA. cltaylor@usc.edu
Robert J Hartsock

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

'Nowhere in pathology has a chaos of names so clouded clear concepts as in the subject lymphoid tumors'. R.A. Willis. In 1858, Rudolf Virchow, with a primitive microscope and limited experiential base, recognized 'at least three different conditions here, hyperinosis, leucocytosis and leukemia….'. One hundred and fifty years later, the World Health Organization (WHO 2008), with a much more extensive armamentarium of tools, and a wealth of diverse experience, promulgated criteria distinguishing more than 100 types of 'Tumors of the Hematopoietic and Lymphoid Tissues'. From three to one hundred and three; this is progress! And this is history! Our goal is to examine the course and causes of this history; how we moved from three entities to a hundred and three, what we have learned from it, and how we may use the insights that we have gained to anticipate 'future histories' in this marvelously dynamic area of biology and disease.

Indexed as

History, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansLeukemiaLeukocytosisLymphomaMicroscopyTerminology as TopicWorld Health Organization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.